Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease.

[1]  L. Lerman,et al.  Renovascular hypertension and ischemic nephropathy. , 2010, American journal of hypertension.

[2]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[3]  P. Kalra,et al.  The Effects of Statins on the Progression of Atherosclerotic Renovascular Disease , 2007, Nephron Clinical Practice.

[4]  N. Ives,et al.  Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far , 2007, Journal of Human Hypertension.

[5]  E. Ritman,et al.  Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  S. Kato,et al.  Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. , 2007, Vascular pharmacology.

[7]  W. Meyer-Sabellek,et al.  Atherosclerosis, inflammation, leukocyte function and the effect of statins. , 2006, Journal of hypertension.

[8]  H. Gavras,et al.  Frequency of coronary artery disease in patients with renal artery stenosis without clinical manifestations of coronary insufficiency. , 2006, American journal of hypertension.

[9]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[10]  C. Napoli,et al.  The FASEB Journal • FJ Express Full-Length Article Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia , 2022 .

[11]  M. Tonelli,et al.  Statins for improving renal outcomes: a meta-analysis. , 2006, Journal of the American Society of Nephrology : JASN.

[12]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[13]  R. D'Agostino,et al.  The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. , 2005, Journal of vascular and interventional radiology : JVIR.

[14]  L. Lupattelli,et al.  Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Egido,et al.  Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One Month , 2005, Stroke.

[16]  J. Deanfield,et al.  Beyond the Laboratory: Clinical Implications for Statin Pleiotropy , 2004, Circulation.

[17]  Filippo Cademartiri,et al.  Images in cardiovascular medicine. Pseudoaneurysms of the ascending aorta demonstrated with "motion-free" multislice computed tomography. , 2004, Circulation.

[18]  J. V. van Engelshoven,et al.  The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. , 2003, Journal of nephrology.

[19]  W. Chen,et al.  Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease , 2003, Internal medicine journal.

[20]  A. Iskandrian,et al.  Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. , 2003, Journal of hypertension.

[21]  F. Neumann,et al.  Survival after Stenting of Severe Atherosclerotic Ostial Renal Artery Stenoses , 2003, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[22]  F. Beek,et al.  Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[24]  J. Wolfe,et al.  Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease , 2002, The British journal of surgery.

[25]  P. Krijnen,et al.  The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. , 2000, The New England journal of medicine.

[26]  P. Kalra,et al.  Proteinuria in atherosclerotic renovascular disease. , 1999, QJM : monthly journal of the Association of Physicians.

[27]  H. Lachmann,et al.  Improvement in renal cholesterol emboli syndrome after simvastatin , 1998, The Lancet.

[28]  J. Webster,et al.  Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis , 1998, Journal of Human Hypertension.

[29]  Pierre-François Plouin,et al.  Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. , 1998, Hypertension.

[30]  Y. Ubara,et al.  Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney. , 1997, Clinical nephrology.